I

Innocan Pharma Corp
OTC:INNPF

Watchlist Manager
Innocan Pharma Corp
OTC:INNPF
Watchlist
Price: 5.46 USD Market Closed
Market Cap: $1.5B

Profitability Summary

Innocan Pharma Corp's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
Innocan Pharma Corp

Margins Comparison
Innocan Pharma Corp Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IL
Innocan Pharma Corp
CNSX:INNO
30.4m CAD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
415.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.9B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.2B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Innocan Pharma Corp Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
Innocan Pharma Corp
CNSX:INNO
30.4m CAD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
951.3B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
595.7B USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
415.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
244.9B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
231.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
297.5B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1T DKK
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Innocan Pharma Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett